This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Rare Disease Conference 2024 - Rare Disease Summit
March 18-20, 2025
Pre-Conference Workshops on March 17, 2025Sheraton Philadelphia Downtown | Philadelphia, PA

Anish Bhatnagar
CEO at Soleno Therapeutics


Dr. Bhatnagar, CEO of Soleno since its inception in 2017, brings over 20 years of medical expertise to the biopharmaceutical and medical device industries. His extensive background encompasses the development of biologics, drugs, drug-device combinations, and diagnostic/therapeutic medical devices. Notable contributions include products like Bexxar, Probuphine, Serenz, and CoSense. Prior to Soleno, he served as CEO of Capnia, Inc. His career journey includes roles at Coulter Pharmaceuticals, Inc. and Titan Pharmaceuticals, Inc. Dr. Bhatnagar, a published author, earned his medical degree at SMS Medical College, Jaipur, India, and completed Residency and Fellowship training at institutions including Georgetown University Hospital and the University of Pennsylvania.

Agenda Sessions

  • Navigating the Unchartered – Fireside Chat with Rare Disease Pharma Pioneers